YOLFTbeta
HP

The Hydration Pharmaceuticals Company Ltd

HPC · AU · Consumer Defensive / Food Distribution

0.003AUD+0.00 (+50.00%)

Price History

Full chart

Market Stats

Previous Close0.002
Open0.003
Day Range0.003 – 0.003
52-Week Range0.003 – 0.011
Volume1.02M
Market Cap1.61M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.95
50-Day Avg0.0036
200-Day Avg0.0041

About

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. It sells its products under the Hydralyte brand through retail stores and online. The company was founded in 2001 and is based in Melbourne, Australia.

Company Details

  • SectorConsumer Defensive
  • IndustryFood Distribution
  • CEOMs. Victoria Alexis Nadalin
  • Employees0
  • Headquarters6 Palmer Parade, Cremorne, Melbourne, VIC, Australia, 3121, Australia
  • Websitehttps://hydralyte.com

Leadership

  • Ms. Victoria Alexis NadalinCompany Secretary

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.16M2.96M3.76M6.13M9.10M10.04M3.20M2.56M
Growth (%)--28.80%+26.79%+63.10%+48.52%+10.34%-68.08%-20.19%
Cost of Revenue4.24M1.59M2.42M3.34M4.40M4.65M1.58M2.59M
Gross Profit-75.26K1.38M1.34M2.79M4.70M5.39M1.62M-27.42K
Gross Margin-1.81%46.45%35.55%45.53%51.61%53.70%50.57%-1.07%
Operating Expense9.18M4.78M4.61M10.29M15.21M12.26M5.82M3.23M
Operating Income-9.26M-3.40M-3.28M-7.50M-10.52M-6.87M-4.20M-3.26M
Operating Margin-222.47%-114.77%-87.21%-122.35%-115.56%-68.37%-130.95%-127.29%
EBITDA-9.18M-3.39M-3.28M-6.08M-10.52M-7.46M-3.91M-3.26M
EBITDA Margin-220.61%-114.38%-87.21%-99.27%-115.56%-74.29%-122.02%-127.29%
Net Income-9.60M-3.43M-743.66K-8.97M-10.61M-8.10M2.67M-2.96M
Net Income Margin-230.76%-115.91%-19.80%-146.34%-116.56%-80.69%83.23%-115.74%
Interest Expense354.14K34.03K258.87K3.64M91.21K642.90K1.76M74.51
Interest Expense % of Total Revenue8.51%1.15%6.89%59.41%1.00%6.40%55.03%0.00%

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.24M4.20M4.45M15.31M10.39M6.69M5.00M2.19M
Total Liabilities1.58M1.76M2.44M2.08M6.41M7.05M2.25M774.76K
Total Equity2.62M2.39M2.00M13.23M3.98M-358.25K2.74M1.42M
Cash2.54M2.74M1.64M10.67M4.69M1.84M3.22M1.12M
Total Debt----3.71M3.89M--
Net Debt-2.54M-2.74M-1.64M-10.67M-976.41K2.05M-3.22M-1.12M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.40M-2.78M-3.86M-8.08M-9.75M-5.73M-3.02M-3.78M
Investing Cash Flow0-20.48K2.73M-2.15K--9.44M0
Financing Cash Flow03.04M17.03M17.03M4.08M2.72M-3.63M833.93K
Capital Expenditure020.48K18.07K00000
Free Cash Flow-5.40M-2.80M-3.88M-8.08M-9.75M-5.73M-3.02M-3.78M
FCF to OCF100.00%100.74%100.47%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateAug 30, 2024Aug 29, 2025
EPS Estimate0.000.00
EPS Actual-0.010.00
Surprise--
Timing--

Key Statistics & Ratios

Market Cap1.61M
Enterprise Value991.17K
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.75
Price / Book1.75
EPS-0.01
Book Value0.0014
Revenue (TTM)2.15M
Gross Profit (TTM)1.03M
EBITDA-10.70M
Profit Margin-115.36%
Operating Margin-102.28%
Return on Equity-147.39%
Return on Assets-65.54%
Shares Outstanding537.99M
Shares Float219.60M
Beta0.95
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%